Company presentations & Media
15 November 2023
Antisense Therapeutics Annual General Meeting 2023 Presentation
8 September 2023
Antisense Therapeutics presents to ShareCafe Hidden Gems
28 August 2023
Antisense Therapeutics Open House (Melbourne)
August 2023
Corporate Presentation
PPMD Annual Conference 2023 29 June to 1 July 2023
ATL1102, Targeting Inflammation In DMD and Clinical Development Update
23 March 2023
A Finance News Network interview with Elliott Dean, a top shareholder in ANP, discusses his investing philosophy
26 February 2023
CEO Mark Diamond - Interview on eHealth Radio Network
1 December 2022
CEO Mark Diamond - Interview with Jane King
November 2022
Investor Presentation
4 November 2022
Emerging ASX Gems Presentation by Mark Diamond
Aug 2022
Long Covid-19 Collaboration Outcomes
Evaluating a novel antisense oligonucleotide treatment for DMD
Science/AAAS Webinar
Mitigating Inflammation in DMD and Clinical Development Update
PPMD 2022 Conference Presentation
ATL1102 PROTEOMICS MDA Poster March 13 2022
Muscular Dystrophy Association Conference
Hear from Managing Director & CEO – Mark Diamond
Sharecafe Due Diligence Webinar
Full Poster PDF – WMS 2021
World Muscle Society 2021 Congress
Antisense corporate video overview
Corporate Video
